Ashutosh Wechalekar

19PUBLICATIONS
148CO-AUTHORS
AutoimmunityBioinformatic methods developmentPalliative careRheumatology and arthritisCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

|Dec 07, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System.

Jahanzaib Khwaja, Amy A Kirkwood, Paolo Milani

|Oct 16, 2025
A collaborative approach to amyloidosis and a multidisciplinary care framework - position statement from the International Society of Amyloidosis.

Vaishali Sanchorawala, Ashutosh Wechalekar, Peter Mollee

|Aug 12, 2025
Prognostic value of right ventricular longitudinal strain assessed by multimodal imaging in amyloidosis: systematic review and meta-analysis.

Javier Herrera-Flores, Robin W M Vernooij, Arjun K Ghosh

|Jul 19, 2023
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.

Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos

|Jan 25, 2023
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.

Giovanni Palladini, Stefan Schönland, Giampaolo Merlini

Pageof 4

Frequent Collaborators

5 joint publications

Vaishali Sanchorawala

4 joint publications

Efstathios Kastritis

4 joint publications

Shaji Kumar

3 joint publications

Sriram Ravichandran